Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557–88.

Article  PubMed  PubMed Central  Google Scholar 

Huang YH, Zhang CZ, Huang QS, et al. Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma. J Hepatol. 2021;74:838–49.

Article  CAS  PubMed  Google Scholar 

Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006;124:837–48.

Article  CAS  PubMed  Google Scholar 

de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13:607–15.

Article  PubMed  Google Scholar 

Iida N, Dzutsev A, Stewart CA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science (New York, NY). 2013;342:967–70.

Article  CAS  Google Scholar 

Garrett WS. Cancer and the microbiota. Science (New York, NY). 2015;348:80–6.

Article  CAS  Google Scholar 

Nejman D, Livyatan I, Fuks G, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science (New York, NY). 2020;368:973–80.

Article  CAS  Google Scholar 

Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14:207–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Le Noci V, Guglielmetti S, Arioli S, et al. Modulation of pulmonary microbiota by antibiotic or probiotic aerosol therapy: a strategy to promote immunosurveillance against lung metastases. Cell Rep. 2018;24:3528–38.

Article  PubMed  Google Scholar 

Herraez E, Romero MR, Macias RIR, et al. Clinical relevance of the relationship between changes in gut microbiota and bile acid metabolism in patients with intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr. 2020;9:211–4.

Article  PubMed  PubMed Central  Google Scholar 

Zhou SL, Dai Z, Zhou ZJ, et al. CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils. Carcinogenesis. 2014;35:597–605.

Article  CAS  PubMed  Google Scholar 

Wittekind C. Pitfalls in the classification of liver tumors. Pathologe. 2006;27:289–93.

Article  CAS  PubMed  Google Scholar 

Davis NM, Proctor DM, Holmes SP, et al. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome. 2018;6:226.

Article  PubMed  PubMed Central  Google Scholar 

Magoč T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics (Oxford, England). 2011;27:2957–63.

PubMed  Google Scholar 

Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bokulich NA, Subramanian S, Faith JJ, et al. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods. 2013;10:57–9.

Article  CAS  PubMed  Google Scholar 

Edgar RC, Haas BJ, Clemente JC, et al. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics (Oxford, England). 2011;27:2194–200.

CAS  PubMed  Google Scholar 

Haas BJ, Gevers D, Earl AM, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011;21:494–504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10:996–8.

Article  CAS  PubMed  Google Scholar 

Quast C, Pruesse E, Yilmaz P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41:D590-596.

Article  CAS  PubMed  Google Scholar 

Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greathouse KL, White JR, Vargas AJ, et al. Interaction between the microbiome and TP53 in human lung cancer. Genome Biol. 2018;19:123.

Article  PubMed  PubMed Central  Google Scholar 

Pushalkar S, Hundeyin M, Daley D, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer Discov. 2018;8:403–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang W, Chen CH, Jia M, et al. Tumor-associated microbiota in esophageal squamous cell carcinoma. Front Cell Dev Biol. 2021;9: 641270.

Article  PubMed  PubMed Central  Google Scholar 

Gao Z, Guo B, Gao R, et al. Microbiota disbiosis is associated with colorectal cancer. Front Microbiol. 2015;6:20.

Article  PubMed  PubMed Central  Google Scholar 

Riquelme E, Zhang Y, Zhang L, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178:795-806.e712.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mima K, Nishihara R, Qian ZR, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016;65:1973–80.

Article  CAS  PubMed  Google Scholar 

Yamamura K, Izumi D, Kandimalla R, et al. Intratumoral fusobacterium nucleatum levels predict therapeutic response to neoadjuvant chemotherapy in esophageal squamous cell carcinoma. Clin Cancer Res. 2019;25:6170–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33:496–503.

Article  CAS  PubMed  Google Scholar 

Huang C, Li M, Liu B, et al. Relating gut microbiome and its modulating factors to immunotherapy in solid tumors: a systematic review. Front Oncol. 2021;11: 642110.

Article  PubMed  PubMed Central  Google Scholar 

Zhou SL, Zhou ZJ, Hu ZQ, et al. Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib. Gastroenterology. 2016;150(1646–1658): e1617.

Google Scholar 

Zhou SL, Zhou ZJ, Hu ZQ, et al. Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence. J Hepatol. 2019. https://doi.org/10.1016/j.jhep.2019.07.014.

Article  PubMed  PubMed Central  Google Scholar 

Zhou SL, Yin D, Hu ZQ, et al. A positive feedback loop between cancer stem-like cells and tumor-associated neutrophils controls hepatocellular carcinoma progression. Hepatology. 2019;70:1214–30.

Article  CAS  PubMed  Google Scholar 

Tian MX, Zhou YF, Qu WF, et al. Histopathology-based immunoscore predicts recurrence for intrahepatic cholangiocarcinoma after hepatectomy. Cancer Immunol Immunother. 2019;68:1369–78.

Article  CAS  PubMed  Google Scholar 

Zhang R, Li Q, Fu J, et al. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma. BMC Cancer. 2021;21:112.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Z, Wang P, Sun R, et al. Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3. J Immunother Cancer. 2021. https://doi.org/10.1136/jitc-2020-001946.

Article  PubMed  PubMed Central  Google Scholar 

Zhou SL, Xin HY, Sun RQ, et al. Association of KRAS variant subtypes with survival and recurrence in patients with surgically treated intrahepatic cholangiocarcinoma. JAMA Surg. 2022;157:59–65.

Article  PubMed  Google Scholar 

Zhou SL, Luo CB, Song CL, et al. Genomic evolution and the impact of SLIT2 mutation in relapsed intrahepatic cholangiocarcinoma. Hepatology. 2022;75:831–46.

Article  CAS  PubMed